Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | ALB | P02768 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | TK1 | P04183 | 4/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | TYMP | P19971 | 1/20 | 0.38 |
| ▸ | RNASE1 | P07998 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2012504 | 0.81 | ALDH1A1 (0.43) | ALDH1A1LMNAALBPOLBADRA1A | |
| SCHEMBL28765909 | 0.81 | LMNA (0.42) | ALDH1A1LMNAALBPOLBADRA1A | |
| SCHEMBL3611848 | 0.81 | LMNA (0.41) | ALDH1A1LMNAALBPOLBADRA1A | |
| SCHEMBL30841853 | 0.81 | ALDH1A1 (0.41) | ALDH1A1LMNAALBPOLBADRA1A | |
| SCHEMBL1878105 | 0.81 | ALDH1A1 (0.43) | ALDH1A1LMNAALBPOLBADRA1A | |
| SCHEMBL27583424 | 0.81 | ALDH1A1 (0.41) | ALDH1A1LMNAALBPOLBADRA1A | |
| SCHEMBL339966 | 0.81 | ALDH1A1 (0.41) | ALDH1A1LMNAALBPOLBADRA1A | |
| SCHEMBL3694341 | 0.80 | TK1 (0.43) | TK1TYMPRNASE1 | |
| SCHEMBL2633815 | 0.80 | LMNA (0.41) | ALDH1A1LMNAALBPOLBADRA1A | |
| SCHEMBL28016980 | 0.79 | ALDH1A1 (0.40) | ALDH1A1LMNAALBPOLBADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250207121-A1 | METHODS FOR THE REMOVAL OF DOUBLE-AND/OR MULTI-STRANDED NUCLEIC ACID IMPURITIES FROM RNA PREPARATIONS BY LOW pH TREATMENT | Sartorius BIA Separations D.O.O (SI) | 2025-06-26 | — | — | US | disclosed |
| WO-2023194562-A1 | METHODS FOR THE REMOVAL OF DOUBLE- AND/OR MULTI-STRANDED NUCLEIC ACID IMPURITIES FROM RNA PREPARATIONS BY LOW pH TREATMENT | SARTORIUS BIA SEPARATIONS D.O.O. (SI) | 2023-10-12 | — | — | WO | disclosed |
| EP-4257685-A1 | METHODS FOR THE REMOVAL OF DOUBLE- AND/OR MULTI-STRANDED NUCLEIC ACID IMPURITIES FROM RNA PREPARATIONS BY LOW PH TREATMENT | Sartorius BIA Separations d.o.o. (SI) | 2023-10-11 | — | — | EP | disclosed |
| US-7608402-B2 | DNA methylation specific signal amplification | LI WEIWEI | 2009-10-27 | — | — | US | disclosed |
| US-20090181373-A1 | DNA methylation specific signal amplification | LI WEIWEI | 2009-07-16 | — | — | US | disclosed |
| CN-1780922-A | Compositions and methods for the treatment of severe acute respiratory syndrome (SARS) | ISIS PHARMACEUTICALS INC (US) | 2006-05-31 | — | — | CN | disclosed |